The Serine Protease Omi/HtrA2 Regulates Apoptosis by Binding XIAP through a Reaper-like Motif*
By L. M. Martins, I. Iaccarino, T. Tenev, S. Gschmeissner, N. Totty, N. Lemoine, J. Savopoulos, C. Gray, C. Creasy, C. Dingwall and 1 more. Journal of Biological Chemistry, 2002
601 citations recorded by the source corpus.
The inhibitor-of-apoptosis proteins (IAPs) play a critical role in the regulation of apoptosis by binding and inhibiting caspases. Reaper family proteins and Smac/DIABLO use a conserved amino-terminal sequence to bind to IAPs in flies and mammals, respectively, blocking their ability to inhibit caspases and thus promoting apoptosis. Here we have identified the serine protease Omi/HtrA2 as a second mammalian XIAP-binding protein with a Reaper-like motif. This protease autoprocesses to form a protein with amino-terminal homology to Smac/DIABLO and Reaper family proteins. Full-length Omi/HtrA2 is localized to mitochondria but fails to interact with XIAP. Mitochondria also contain processed Omi/HtrA2, which, following apoptotic insult, translocates to the cytosol, where it interacts with XIAP. Overexpression of Omi/HtrA2 sensitizes cells to apoptosis, and its removal by RNA interference reduces cell death. Omi/HtrA2 thus extends the set of mammalian proteins with Reaper-like function that are released from the mitochondria during apoptosis.
Subfields: Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/092e1238b19599cf30fbf20ba6a741f5736e7bee
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Molecular Biology
Citations in the corpus
- Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. (2002, background): “Very recently, siRNA was also used to knock down expression of HtrA2 (28).”
- Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. (2005, background): “We confirmed the previously reported predominant mitochondrial localization of Omi/HtrA2 protein in cells as assessed by immunofluorescence (4,6) (Fig.”
- Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy (2006, background): “Decreasing the levels of HtrA2/OMI in cells by antisense or RNA interference lowers the sensitivity of different cancer cell lines to cell death induced by staurosporin, Fas, UV or cisplatin (Martins et al., 2002).”
- Bcl-2-family proteins and the role of mitochondria in apoptosis. (2003, background): “The contribution of the intrinsic pathway in such cases could be mediated by any of several IMS proteins, including cytochrome c, Smac/DIABLO [20,21], Omi/Htra2 [22–24], endonuclease G [25] and apoptosis-inducing factor (AIF) [26,27].”
- Toxic proteins released from mitochondria in cell death (2004, background): “Processing of this second leader, which occurs in a subpopulation of the HtrA2/ OMI pool, exposes an IBM and generates mature 35 kDa HtrA2/OMI (Suzuki et al., 2001a; Hegde et al., 2002; Martins et al., 2002; van Loo et al., 2002b; Verhagen et al., 2002).”